Silvia Mezi

2.2k total citations · 1 hit paper
51 papers, 1.4k citations indexed

About

Silvia Mezi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Silvia Mezi has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Silvia Mezi's work include Cancer Immunotherapy and Biomarkers (14 papers), Head and Neck Cancer Studies (8 papers) and Medical Imaging Techniques and Applications (5 papers). Silvia Mezi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Head and Neck Cancer Studies (8 papers) and Medical Imaging Techniques and Applications (5 papers). Silvia Mezi collaborates with scholars based in Italy, United Kingdom and Germany. Silvia Mezi's co-authors include Chiara Cremolini, Marina Elena Cazzaniga, Mauro D’Amico, Giuseppe Tonini, Luca Boni, Giacomo Allegrini, Elisa Sensi, Sara Lonardi, Cristiana Lupi and Monica Ronzoni and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Silvia Mezi

47 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

2015 733 citations Silvia Mezi, Alfredo Falcone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvia Mezi Italy	15	1.0k	416	292	252	240	51	1.4k
Ірина Давиденко United States	16	807 0.8×	583 1.4×	286 1.0×	403 1.6×	284 1.2×	33	1.6k
Felix Chu United States	12	632 0.6×	539 1.3×	251 0.9×	588 2.3×	260 1.1×	19	1.7k
Thomas Makatsoris Greece	22	1.0k 1.0×	338 0.8×	135 0.5×	362 1.4×	147 0.6×	85	1.5k
Wenzhuo He China	19	878 0.9×	279 0.7×	184 0.6×	241 1.0×	296 1.2×	84	1.3k
Epaminontas Samantas Greece	18	857 0.8×	621 1.5×	115 0.4×	248 1.0×	232 1.0×	62	1.2k
Yoshiki Kajiwara Japan	24	1.4k 1.4×	457 1.1×	412 1.4×	191 0.8×	590 2.5×	80	1.8k
Roberto Carmagnani Pestana United States	17	547 0.5×	279 0.7×	125 0.4×	217 0.9×	133 0.6×	52	1.1k
Hironaga Satake Japan	18	667 0.7×	573 1.4×	130 0.4×	97 0.4×	372 1.6×	147	1.1k
Robert C. Hermann United States	15	1.0k 1.0×	868 2.1×	449 1.5×	397 1.6×	241 1.0×	38	1.8k
K. Park South Korea	13	664 0.7×	482 1.2×	224 0.8×	196 0.8×	201 0.8×	43	994

Countries citing papers authored by Silvia Mezi

Since Specialization

Citations

This map shows the geographic impact of Silvia Mezi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Mezi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Mezi more than expected).

Fields of papers citing papers by Silvia Mezi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Mezi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Mezi. The network helps show where Silvia Mezi may publish in the future.

Co-authorship network of co-authors of Silvia Mezi

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Mezi. A scholar is included among the top collaborators of Silvia Mezi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Mezi. Silvia Mezi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mezi, Silvia, Andrea Botticelli, Giulia Pomati, et al.. (2025). Impact of Drug–Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real‐World Study. Pigment Cell & Melanoma Research. 38(4). e70026–e70026.

Cirillo, Alessio, Daniele Marinelli, Umberto Romeo, et al.. (2024). Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis. BMC Cancer. 24(1). 430–430. 4 indexed citations

Mezi, Silvia, Giulia Pomati, Giulia Fiscon, et al.. (2023). A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors. Frontiers in Immunology. 14. 1199089–1199089.

Mezi, Silvia, Andrea Botticelli, Simone Scagnoli, et al.. (2023). The Impact of Drug–Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma. Cancers. 15(18). 4587–4587. 6 indexed citations

Valentini, Virginia, Valentina Silvestri, Giulia Pomati, et al.. (2023). Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology. Frontiers in Oncology. 12. 1092201–1092201. 7 indexed citations

Brauner, Edoardo, Valentino Valentini, Umberto Romeo, et al.. (2022). Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up. Diagnostics. 12(8). 1863–1863.

Botticelli, Andrea, Alessio Cirillo, Bruna Cerbelli, et al.. (2022). Suppressive immune profile in combined positive score positive head and neck cancer patients treated with immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). e18014–e18014. 1 indexed citations

Botticelli, Andrea, Giulia Pomati, Alessio Cirillo, et al.. (2022). The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy. Frontiers in Immunology. 13. 974087–974087. 12 indexed citations

Mezi, Silvia, Andrea Botticelli, Giulia Pomati, et al.. (2021). Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer. Cancers. 13(5). 1080–1080. 14 indexed citations

10.

Brauner, Edoardo, Silvia Mezi, Resi Pucci, et al.. (2021). A New Medical Record Proposal to the Prognostic Risk Assessment for MRONJ in Oncologic Patients: “Sapienza Head and Neck Unit” Proposal. International Journal of Environmental Research and Public Health. 18(4). 1851–1851. 2 indexed citations

11.

Botticelli, Andrea, Alessio Cirillo, Lidia Strigari, et al.. (2021). Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis. Frontiers in Immunology. 12. 705096–705096. 67 indexed citations

12.

Botticelli, Andrea, Alessio Cirillo, Giulia Pomati, et al.. (2021). The role of opioids in cancer response to immunotherapy. Journal of Translational Medicine. 19(1). 119–119. 29 indexed citations

13.

Cerbelli, Bruna, Simone Scagnoli, Silvia Mezi, et al.. (2020). Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer. Cancers. 12(9). 2648–2648. 18 indexed citations

14.

Botticelli, Andrea, Silvia Mezi, Giulia Pomati, et al.. (2020). Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1. Frontiers in Immunology. 11. 1243–1243. 34 indexed citations

15.

Cortesi, Enrico, S Caponnetto, Gianluca Masi, et al.. (2020). Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 19(4). e272–e276. 1 indexed citations

16.

Cortesi, Enrico, Gianluca Masi, Maria Mancini, et al.. (2016). Radioembolization (SIRT) as a consolidation treatment in colorectal liver metastases after first line chemotherapy.. Journal of Clinical Oncology. 34(15_suppl). e15007–e15007. 2 indexed citations

17.

Mezi, Silvia, et al.. (2012). Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells. International Journal of Oncology. 41(6). 2128–2138. 30 indexed citations

18.

Iacovelli, Roberto, Antonella Palazzo, Silvia Mezi, et al.. (2012). Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials. Acta Oncologica. 51(7). 873–879. 51 indexed citations

19.

Mezi, Silvia, et al.. (1999). 99m Tc MIBI prone scintimammography in breast Paget's disease: a case report.. Oncology Reports. 6(1). 45–8. 1 indexed citations

20.

Mezi, Silvia, G Tumino, D. Mentuccia, et al.. (1999). [Changes in the organization of the extracellular matrix at the skin level during diabetes].. PubMed. 20(6-7). 277–84. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact